NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Former Telecom chair Wayne Boyd honoured
Finance

Former Telecom chair Wayne Boyd honoured

Honours recognition for a lifetime of low-key, high-quality leadership.

Pattrick Smellie 02 Jun 2025
My Net Worth: Patrick Gamble, CEO Perpetual Guardian
Editor's Picks

My Net Worth: Patrick Gamble, CEO Perpetual Guardian

“If you stand still, you don't do very well.”    

On the Money: Hawkesby, Paris, Mowbray, Peters, and more
Editor's Picks

On the Money: Hawkesby, Paris, Mowbray, Peters, and more

Christian Hawkesby plays coy with the top job while AI threatens all the other jobs.

Dileepa Fonseka 31 May 2025
Liquidator Damien Grant survives bid to remove him
Property

Liquidator Damien Grant survives bid to remove him

The $200m Ormiston Rise housing project has been the subject of ongoing legal battles.

Maria Slade 30 May 2025